Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open‐Label, Randomized Control Study
暂无分享，去创建一个
H. Takada | Y. Mizuno | T. Hara | S. Ohga | K. Hatae | J. Kishimoto | K. Yamamura | T. Ohno | E. Nanishi | H. Nishio | Yasuhiko Takahashi | T. Shimose | H. Yamashita | H. Nakayama | R. Kadoya | M. Fukazawa | K. Furuno | Kenjiro Saigo | N. Ohbuchi | Y. Onoe | Takuya Hara | Tatsuo Harada | T. Hara | Kenichiro Yamamura